Vanguard Health Care ETF (VHT) Latest News, Market Updates & Sentiment | Edgen
Back
Home
Stock
VHT
Vanguard Health Care ETF (VHT)
VHT Stock Price Chart
VHT
Vanguard Health Care ETF
$302.43
0.33%
$1
At close: Jun 29, 16:00:00 GMT-4
$302
-0.14%
$-0.43
Post-market: Jun 29, 20:00:00 GMT-4
Overview
Forecast
Holdings
News
Article
Key Stats
Prev.Close
$301.43
Open
$302.2
Day's Range
$300.61 - $302.76
52 week range
$237.23 - $302
Volume
246.4K
Avg.Volume
215.0K
Dividend yield
1.68%
Net Assets
$0
NAV
--
Expense Ratio
--
Shares Outstanding
59.7M
What is VHT?
VHT was created on 2004-01-26 by Vanguard. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 17006.0m in AUM and 403 holdings. The fund tracks a market-cap-weighted index of US healthcare stocks.
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Crypto Comparison
Home Page
Markets
US Stocks
HK Stocks
Crypto
News
Analyst Moves
Market Moves
Hong Kong IPO
Earnings
AI & Technology
Macro & Policy
Terms of Use
Privacy Policy
Sitemap
© 2026 Edgen Powered by
FDA picks 7 drugmakers for pilot to speed factory reviews
Jun 29 2026, 19:25
J&J's Tecvayli combo cuts myeloma progression risk by 83.4%
Jun 29 2026, 16:58
Four biotech giants hit new 52-week highs as sector rallies 9%
Jun 29 2026, 16:30
Eli Lilly rises 2% pre-market after positive Phase 3 trial data
Jun 29 2026, 12:19
Sandoz wins FDA review for 2 generic tirzepatide GLP-1s
Jun 29 2026, 09:58
AbbVie's upadacitinib secures positive CHMP opinion for vitiligo, first systemic option
Jun 29 2026, 08:21
DOJ closes Abbott formula probe tied to 2 infant deaths
Jun 29 2026, 07:23
Medicare to cover obesity drugs at $50 copay starting July 1
Jun 28 2026, 12:24
UnitedHealth climbs 80% from low as margins recover, DOJ probe lingers
Jun 27 2026, 10:54
Eli Lilly surges 7.5% as weight loss drugs, cancer pipeline drive gains
Jun 27 2026, 00:57
GLP-1 pill launches risk 2027 employer coverage cuts for 1 in 10 plans
Jun 26 2026, 14:54
Eli Lilly jumps 6%, Johnson & Johnson hits record as pharma stocks rally
Jun 26 2026, 14:44
Lilly's Jaypirca wins CHMP backing for CLL across all lines of therapy
Jun 26 2026, 11:56
RAISE US consortium enlists 6 corporate giants for AI workforce shift
Jun 25 2026, 09:11
ALZpath, Abbott sign global licensing deal for Alzheimer's blood test
Jun 24 2026, 11:58
Global tech rout deepens as Nasdaq slides 2.2% on rate and AI fears
Jun 24 2026, 06:40
Abbisko expands Lilly drug deal to $1.9 billion across multiple targets
Jun 24 2026, 01:49
Huyabio inks up to $1.9B licensing deal with Eli Lilly
Jun 24 2026, 00:30